New combo therapy aims to shrink rectal tumors without removing lymph nodes
NCT ID NCT07394192
First seen Feb 06, 2026 · Last updated May 08, 2026 · Updated 11 times
Summary
This study tests whether a short course of radiation that spares the lymph nodes, followed by an immunotherapy drug (PD-1 inhibitor), can completely eliminate rectal cancer before surgery. It includes 44 adults with stage II-III rectal cancer. The goal is to see if this approach leads to a complete response, meaning no cancer remains in the removed tissue.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.